Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Rabinson

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Fertility and Sterility|August 8, 2007
Ultrashort gonadotropin-releasing hormone agonist combined with flexible multidose gonadotropin-releasing hormone antagonist for poor responders in in vitro fertilization/embryo transfer programsRaoul Orvieto, Jenny Kruchkovich, Jacob Rabinson, et al.
Fertility and Sterility|May 12, 2007
Does methotrexate treatment for ectopic pregnancy influence the patient's performance during a subsequent in vitro fertilization/embryo transfer cycle?Raoul Orvieto, Jenya Kruchkovich, Efraim Zohav, et al.
Fertility and Sterility|May 13, 2008
Is there a limit for the number of in vitro fertilization cycles for an individual patient?Roy Homburg, Simion Meltcer, Jacob Rabinson, et al.
Fertility and Sterility|February 6, 2008
Does day 3 luteinizing-hormone level predict IVF success in patients undergoing controlled ovarian stimulation with GnRH analogues?Raoul Orvieto, Simion Meltzer, Jacob Rabinson, et al.
Fertility and Sterility|May 15, 2007
Does physicians' experience influence in vitro fertilization success in patients undergoing controlled ovarian hyperstimulation with GnRH antagonists?Raoul Orvieto, Jacob Rabinson, Simion Meltcer, et al.
Fertility and Sterility|August 5, 2008
GnRH agonist versus GnRH antagonist in controlled ovarian hyperstimulation: their role in patients with an unfavorable prognosis a prioriRaoul Orvieto, Roy Homburg, Simion Meltcer, et al.
Fertility and Sterility|May 11, 2010
A combined approach to patients with repeated IVF failuresRaoul Orvieto, Simion Meltcer, Gad Liberty, et al.
Fertility and Sterility|October 22, 2008
Repeated in vitro fertilization cycle attempts in patients undergoing controlled ovarian hyperstimulation with use of gonadotropin-releasing hormone antagonistsJacob Rabinson, Jacob Ashkenazi, Roy Homburg, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|May 27, 2010
Human menopausal gonadotropin versus highly purified-hMG in controlled ovarian hyperstimulation for in-vitro fertilisation: does purity improve outcome?Raoul Orvieto, Simion Meltcer, Gad Liberty, et al.
Fertility and Sterility|April 4, 2008
Do stimulation characteristics of the first in vitro fertilization cycle predict pregnancy in women of 40 years old and over?Roy Homburg, Simion Meltcer, Jacob Rabinson, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Fertility and Sterility|August 8, 2007
Ultrashort gonadotropin-releasing hormone agonist combined with flexible multidose gonadotropin-releasing hormone antagonist for poor responders in in vitro fertilization/embryo transfer programsRaoul Orvieto, Jenny Kruchkovich, Jacob Rabinson, et al.
Fertility and Sterility|May 12, 2007
Does methotrexate treatment for ectopic pregnancy influence the patient's performance during a subsequent in vitro fertilization/embryo transfer cycle?Raoul Orvieto, Jenya Kruchkovich, Efraim Zohav, et al.
Fertility and Sterility|May 13, 2008
Is there a limit for the number of in vitro fertilization cycles for an individual patient?Roy Homburg, Simion Meltcer, Jacob Rabinson, et al.
Fertility and Sterility|February 6, 2008
Does day 3 luteinizing-hormone level predict IVF success in patients undergoing controlled ovarian stimulation with GnRH analogues?Raoul Orvieto, Simion Meltzer, Jacob Rabinson, et al.
Fertility and Sterility|May 15, 2007
Does physicians' experience influence in vitro fertilization success in patients undergoing controlled ovarian hyperstimulation with GnRH antagonists?Raoul Orvieto, Jacob Rabinson, Simion Meltcer, et al.
Fertility and Sterility|August 5, 2008
GnRH agonist versus GnRH antagonist in controlled ovarian hyperstimulation: their role in patients with an unfavorable prognosis a prioriRaoul Orvieto, Roy Homburg, Simion Meltcer, et al.
Fertility and Sterility|May 11, 2010
A combined approach to patients with repeated IVF failuresRaoul Orvieto, Simion Meltcer, Gad Liberty, et al.
Fertility and Sterility|October 22, 2008
Repeated in vitro fertilization cycle attempts in patients undergoing controlled ovarian hyperstimulation with use of gonadotropin-releasing hormone antagonistsJacob Rabinson, Jacob Ashkenazi, Roy Homburg, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|May 27, 2010
Human menopausal gonadotropin versus highly purified-hMG in controlled ovarian hyperstimulation for in-vitro fertilisation: does purity improve outcome?Raoul Orvieto, Simion Meltcer, Gad Liberty, et al.
Fertility and Sterility|April 4, 2008
Do stimulation characteristics of the first in vitro fertilization cycle predict pregnancy in women of 40 years old and over?Roy Homburg, Simion Meltcer, Jacob Rabinson, et al.
Pageof 3